Home Industry Reports Custom Research Blogs About Us Contact us

Mesenchymal Stem Cells Market Size & Share, By Product & Services, Workflow, Type, Source Of Isolation, Indication, Application, Regional Forecast, Industry Players, Growth Statistics Report 2023-2030

Report ID: FBI 1465


Published Date: Sep-2023


Format : PDF, Excel

Market Outlook:

Mesenchymal Stem Cells Market size surpassed USD 2.56 Billion in 2022 and is poised to reach USD 7.93 Billion, growing at over 14.72% CAGR between 2023 and 2030. Mesenchymal stem cells, also known as multipotent or stromal cells, have gained considerable attention in the field of regenerative medicine and cell therapy. These cells possess unique properties such as self-renewal, differentiation potential, immunomodulatory effects, and low immunogenicity. As a result, they hold immense therapeutic potential for the treatment of various diseases and conditions.

Base Year Value (2022)

USD 2.56 Billion

18-23 x.x %
24-33 x.x %

CAGR (2023-2030)


18-23 x.x %
24-33 x.x %

Forecast Year Value (2030)

USD 7.93 Billion

18-23 x.x %
24-33 x.x %
Mesenchymal Stem Cells Market

Historical Data Period


Mesenchymal Stem Cells Market

Largest Region

North America

Mesenchymal Stem Cells Market

Forecast Period


Get more details on this report -

Market Dynamics:

Growth Drivers & Opportunity:

1. Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cardiovascular disorders, diabetes, neurodegenerative disorders, and orthopedic conditions has created a need for innovative treatment options. Mesenchymal stem cells offer a promising solution by promoting tissue repair and modulating the immune response, thereby driving market growth.

2. Rising Demand for Cell-based Therapies: The growing demand for advanced cell-based therapies for the treatment of various diseases and injuries is fueling the market for mesenchymal stem cells. These cells can be used to replace damaged or diseased cells, and their potential to differentiate into different tissue types makes them an ideal choice for regenerative medicine.

3. Favorable Regulatory Environment: Governments and regulatory bodies across the globe are increasingly recognizing the potential of mesenchymal stem cells in healthcare. Efforts to streamline the regulatory process and provide guidelines for the use of stem cells in medical applications are creating favorable market conditions.


Industry Restraints & Challenges:

Report Scope

Report CoverageDetails
Segments CoveredProducts And Services, Workflow, Type, Source Of Isolation, Indication, Application, Region
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledThermo Fisher Scientific, Cell Applications, Axol Biosciences., Cytori Therapeutics Inc, STEMCELL Technologies, Cyagen Biosciences., Celprogen Inc, BrainStorm Cell Limited., Stemedica Cell Technologies Inc, Merck KGaA (MilliporeSigma), Lonza, PromoCell GmbH

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

1. Ethical Concerns: Despite the therapeutic potential of mesenchymal stem cells, there are ethical concerns surrounding the use of embryonic stem cells. This has led to a shift towards using adult-derived stem cells, which may limit the availability and scalability of mesenchymal stem cell-based therapies.

2. High Cost of Treatment: The high cost associated with mesenchymal stem cell therapy, including cell isolation, expansion, storage, and administration, presents a significant challenge. Limited reimbursement options and affordability issues hinder the market growth, particularly in developing economies.

3. Technical Limitations: Several technical challenges, such as maintaining cell integrity during in vitro expansion, ensuring consistent quality and potency, and establishing standardized manufacturing processes, pose obstacles to the widespread adoption of mesenchymal stem cell therapies.

Despite these challenges, the mesenchymal stem cells market is expected to witness significant growth in the coming years, driven by advancements in technology, increasing research and development activities, and a better understanding of the therapeutic potential of these cells. With ongoing clinical trials and novel applications being explored, the market for mesenchymal stem cells is expected to expand, offering new opportunities for both academic research and commercial development.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Mesenchymal Stem Cells Market
Mesenchymal Stem Cells Market

Regional Forecast:

North America:

North America is expected to hold a significant share in the mesenchymal stem cells market. The region's well-established healthcare infrastructure, advanced research facilities, and increasing investment in regenerative medicine contribute to its growth. Additionally, the presence of key market players and rising collaborations between academic institutions and industry players further drive the market in this region.

Asia Pacific:

The Asia Pacific region is anticipated to grow rapidly in the mesenchymal stem cells market. Factors such as the rising prevalence of chronic diseases, increasing geriatric population, and growing healthcare expenditure drive the demand for regenerative therapies utilizing mesenchymal stem cells. Furthermore, supportive government initiatives and growing awareness about stem cell therapies contribute to market expansion in this region.


Europe is expected to have a significant market share in the mesenchymal stem cells market due to the region's advanced healthcare infrastructure and favorable reimbursement policies. Moreover, the presence of leading pharmaceutical and biotechnology companies, along with increasing research initiatives, drives market growth. Additionally, collaborations between industry players and research institutions for clinical trials and product development also positively impact the market.

Get more details on this report -

Segmentation Analysis:

Segment: Product Type

Sub-Segment: Adult Stem Cells

Adult stem cells are a key sub-segment in the mesenchymal stem cells market. These cells are derived from various adult tissues such as bone marrow, adipose tissue, and dental pulp. Adult stem cells have gained significant attention due to their potential for differentiation into various cell types. They are used in regenerative medicine for the treatment of various age-related degenerative diseases and tissue repair applications.

Segment: Application

Sub-Segment: Orthopedic Disorders

Orthopedic disorders represent a significant application sub-segment in the mesenchymal stem cells market. These cells are used for the treatment of musculoskeletal conditions such as osteoarthritis, osteoporosis, and bone fractures. Mesenchymal stem cells have the ability to differentiate into bone and cartilage tissue, aiding in the regeneration and repair of damaged joints and bones.

Get more details on this report -

Competitive Landscape:

The mesenchymal stem cells market is highly competitive, with several key players leading the industry. Prominent market players include:

1. Lonza Group AG

2. Thermo Fisher Scientific, Inc.

3. Merck KGaA

4. StemCells, Inc.

5. Celgene Corporation

6. Cellular Dynamics International

7. Miltenyi Biotec

8. PromoCell GmbH

9. Axol Bioscience Ltd.

10. Cyagen Biosciences Inc.

These players focus on product innovation, strategic collaborations, and mergers and acquisitions to gain a competitive edge in the market. They also invest in research and development activities to expand their product portfolio and cater to the evolving needs of the healthcare industry.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Mesenchymal Stem Cells Market Size & Share, By Pro...

RD Code : 24